Join
Live feed
·
INSIDERFilingvia Quantisnow
Lyra Therapeutics Inc. logo

SEC Form 4: Merrifield C Ann bought $20,200 worth of shares (4,000 units at $5.05), increasing direct ownership by 55% to 11,328 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LYRA (Lyra Therapeutics Inc.) and more on Quantisnow.